Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-I”

2,569 trials

Showing 20 of 2,569 results

Not applicableStudy completedNCT04810559
What this trial is testing

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

Who this might be right for
HIV TestingHIV Infections
Unity Health Toronto 600
Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Large-scale testing (Phase 3)Study completedNCT01386294
What this trial is testing

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Who this might be right for
HIV Prevention
CONRAD 2,059
Early research (Phase 1)Study completedNCT00428337
What this trial is testing

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00002196
What this trial is testing

CI-1012 in HIV-Infected Patients

Who this might be right for
HIV Infections
Parke-Davis 32
Early research (Phase 1)Study completedNCT00002427
What this trial is testing

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Who this might be right for
HIV Infections
Research Institute for Genetic and Human Therapy 225
Post-approval studies (Phase 4)Study completedNCT01608269
What this trial is testing

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

Who this might be right for
HiV1- Positive
Therapeutic Concepts 30
Not applicableStudy completedNCT01379703
What this trial is testing

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Who this might be right for
HIV-1 Patients
Abbott 2,288
Not applicableStudy completedNCT05868005
What this trial is testing

Delivering a Multi-disease Screening Tool to Migrant Populations

Who this might be right for
HivHepatitis BHepatitis C+7 more
Barcelona Institute for Global Health 980
Testing effectiveness (Phase 2)Study completedNCT02738502
What this trial is testing

Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors

Who this might be right for
Maternal-fetal Infection Transmission
ANRS, Emerging Infectious Diseases 91
Not applicableStudy completedNCT00000895
What this trial is testing

Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)Study completedNCT00027339
What this trial is testing

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Large-scale testing (Phase 3)UnknownNCT04867083
What this trial is testing

Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 440
Early research (Phase 1)Study completedNCT00594373
What this trial is testing

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07584369
What this trial is testing

Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study

Who this might be right for
HIV -1 InfectionMethamphetamine Use
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableStudy completedNCT00002310
What this trial is testing

SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals
Not applicableStudy completedNCT06643897
What this trial is testing

Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.

Who this might be right for
HIV-1-infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 13
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation